Interleukin 10: Bridging the chasms in the immune landscape of multiple myeloma
[Display omitted] Multiple myeloma (MM) is a complex hematologic malignancy characterized by the abnormal proliferation of plasma cells in the bone marrow, leading to significant clinical challenges and a high burden of morbidity and mortality. Interleukin 10 (IL-10), a cytokine with potent anti-inf...
Saved in:
| Published in | International review of cell and molecular biology Vol. 391; pp. 199 - 222 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Netherlands
Elsevier Inc
2025
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | [Display omitted]
Multiple myeloma (MM) is a complex hematologic malignancy characterized by the abnormal proliferation of plasma cells in the bone marrow, leading to significant clinical challenges and a high burden of morbidity and mortality. Interleukin 10 (IL-10), a cytokine with potent anti-inflammatory properties, has emerged as a critical player in the pathobiology of MM. This work delves into the multifaceted role of IL-10 in MM, exploring its contributions to tumor growth, immune evasion, and drug resistance. Here, we examine IL-10’s interactions with various immune cells within the bone marrow microenvironment and its potential as a circulatory biomarker for MM. Furthermore, we particularly lay emphasis on the prognostic and diagnostic implications of IL-10 levels in MM patients and evaluate the therapeutic prospects of targeting IL-10 in MM treatment regimens. By synthesizing current research, this review aims to enhance the understanding of IL-10 as a circulatory biomarker in MM and to highlight novel avenues for therapeutic intervention, thereby translating to improved clinical outcomes for MM patient. |
|---|---|
| AbstractList | Multiple myeloma (MM) is a complex hematologic malignancy characterized by the abnormal proliferation of plasma cells in the bone marrow, leading to significant clinical challenges and a high burden of morbidity and mortality. Interleukin 10 (IL-10), a cytokine with potent anti-inflammatory properties, has emerged as a critical player in the pathobiology of MM. This work delves into the multifaceted role of IL-10 in MM, exploring its contributions to tumor growth, immune evasion, and drug resistance. Here, we examine IL-10's interactions with various immune cells within the bone marrow microenvironment and its potential as a circulatory biomarker for MM. Furthermore, we particularly lay emphasis on the prognostic and diagnostic implications of IL-10 levels in MM patients and evaluate the therapeutic prospects of targeting IL-10 in MM treatment regimens. By synthesizing current research, this review aims to enhance the understanding of IL-10 as a circulatory biomarker in MM and to highlight novel avenues for therapeutic intervention, thereby translating to improved clinical outcomes for MM patient. [Display omitted] Multiple myeloma (MM) is a complex hematologic malignancy characterized by the abnormal proliferation of plasma cells in the bone marrow, leading to significant clinical challenges and a high burden of morbidity and mortality. Interleukin 10 (IL-10), a cytokine with potent anti-inflammatory properties, has emerged as a critical player in the pathobiology of MM. This work delves into the multifaceted role of IL-10 in MM, exploring its contributions to tumor growth, immune evasion, and drug resistance. Here, we examine IL-10’s interactions with various immune cells within the bone marrow microenvironment and its potential as a circulatory biomarker for MM. Furthermore, we particularly lay emphasis on the prognostic and diagnostic implications of IL-10 levels in MM patients and evaluate the therapeutic prospects of targeting IL-10 in MM treatment regimens. By synthesizing current research, this review aims to enhance the understanding of IL-10 as a circulatory biomarker in MM and to highlight novel avenues for therapeutic intervention, thereby translating to improved clinical outcomes for MM patient. Multiple myeloma (MM) is a complex hematologic malignancy characterized by the abnormal proliferation of plasma cells in the bone marrow, leading to significant clinical challenges and a high burden of morbidity and mortality. Interleukin 10 (IL-10), a cytokine with potent anti-inflammatory properties, has emerged as a critical player in the pathobiology of MM. This work delves into the multifaceted role of IL-10 in MM, exploring its contributions to tumor growth, immune evasion, and drug resistance. Here, we examine IL-10's interactions with various immune cells within the bone marrow microenvironment and its potential as a circulatory biomarker for MM. Furthermore, we particularly lay emphasis on the prognostic and diagnostic implications of IL-10 levels in MM patients and evaluate the therapeutic prospects of targeting IL-10 in MM treatment regimens. By synthesizing current research, this review aims to enhance the understanding of IL-10 as a circulatory biomarker in MM and to highlight novel avenues for therapeutic intervention, thereby translating to improved clinical outcomes for MM patient.Multiple myeloma (MM) is a complex hematologic malignancy characterized by the abnormal proliferation of plasma cells in the bone marrow, leading to significant clinical challenges and a high burden of morbidity and mortality. Interleukin 10 (IL-10), a cytokine with potent anti-inflammatory properties, has emerged as a critical player in the pathobiology of MM. This work delves into the multifaceted role of IL-10 in MM, exploring its contributions to tumor growth, immune evasion, and drug resistance. Here, we examine IL-10's interactions with various immune cells within the bone marrow microenvironment and its potential as a circulatory biomarker for MM. Furthermore, we particularly lay emphasis on the prognostic and diagnostic implications of IL-10 levels in MM patients and evaluate the therapeutic prospects of targeting IL-10 in MM treatment regimens. By synthesizing current research, this review aims to enhance the understanding of IL-10 as a circulatory biomarker in MM and to highlight novel avenues for therapeutic intervention, thereby translating to improved clinical outcomes for MM patient. |
| Author | Ahmad, Aamir Dermime, Said Fernandes, Queenie Ansari, Abdul W. Merhi, Maysaloun Uddin, Shahab Makni-Maalej, Karama |
| Author_xml | – sequence: 1 givenname: Queenie surname: Fernandes fullname: Fernandes, Queenie organization: Translational Cancer Research Facility, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar – sequence: 2 givenname: Abdul W. surname: Ansari fullname: Ansari, Abdul W. organization: Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar – sequence: 3 givenname: Karama surname: Makni-Maalej fullname: Makni-Maalej, Karama organization: Translational Cancer Research Facility, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar – sequence: 4 givenname: Maysaloun surname: Merhi fullname: Merhi, Maysaloun organization: Translational Cancer Research Facility, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar – sequence: 5 givenname: Said surname: Dermime fullname: Dermime, Said organization: Translational Cancer Research Facility, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar – sequence: 6 givenname: Aamir surname: Ahmad fullname: Ahmad, Aamir organization: Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar – sequence: 7 givenname: Shahab surname: Uddin fullname: Uddin, Shahab email: SKan34@hamad.qa organization: Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39939076$$D View this record in MEDLINE/PubMed |
| BookMark | eNo1kMtOwzAQRb0oog_4A4S8ZNMwjlPHYYEEFY9KlbqBteXHpDXESYkTpP49KZTV6GqOrq7OlIzqpkZCrhgkDJi4NTHxrQ0mSSHNEpAJAB-RCSt4PhdZJsdkGuMHgODAF-dkzIuCF5CLCdms6g7bCvtPX1MGd_Sx9W7r6y3tdkjtTscQ6fA6Jh9CXyOtdO2i1XukTUlDX3V-XyENB6yaoC_IWamriJenOyPvz09vy9f5evOyWj6s58gk6-YaTF6AMC4zJbBUaGlkaQ0TApyQeuGGaNCChFS6sjBlmpmML2xh0hyYM3xGbv56923z1WPsVPDRYjWMw6aPig9VqeAZSwf0-oT2JqBT-9YH3R7Uv4QBuP8DcBj87bFV0XqsLTrfou2Ua7xioI6mlYnq17Q6mlYg1WCa_wDkwHWD |
| ContentType | Journal Article |
| Copyright | 2025 Copyright © 2025. Published by Elsevier Inc. |
| Copyright_xml | – notice: 2025 – notice: Copyright © 2025. Published by Elsevier Inc. |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/bs.ircmb.2024.08.003 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EndPage | 222 |
| ExternalDocumentID | 39939076 S1937644824001205 |
| Genre | Journal Article Review |
| GroupedDBID | --- -~X 0R~ 53G 85S 8N7 8NA 8NF AALRI AAXUO ABGWT ABMAC ABQQC ACGFS ACXMD ADVLN ADXHL AENEX AETEA AFFNX AFOST AFTJW AGAMA AHMUE AI. AJBBN AKRWK ALMA_UNASSIGNED_HOLDINGS F5P FA8 FDB HZ~ MVM O9- SBF SDK SES SHL UPT VH1 X7L YZZ CGR CUY CVF ECM EIF NPM UMC 7X8 |
| ID | FETCH-LOGICAL-e181t-a0b7906bd4bf0126a8b8fcb1660d68a5db8fbec08028df9bf24b435c9b2701db3 |
| ISSN | 1937-6448 |
| IngestDate | Fri Jul 11 04:40:44 EDT 2025 Fri May 09 01:30:35 EDT 2025 Tue Jul 29 20:30:48 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Immunotherapy Il-10, Circulatory biomarkers Multiple myeloma |
| Language | English |
| License | Copyright © 2025. Published by Elsevier Inc. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-e181t-a0b7906bd4bf0126a8b8fcb1660d68a5db8fbec08028df9bf24b435c9b2701db3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| PMID | 39939076 |
| PQID | 3166263412 |
| PQPubID | 23479 |
| PageCount | 24 |
| ParticipantIDs | proquest_miscellaneous_3166263412 pubmed_primary_39939076 elsevier_sciencedirect_doi_10_1016_bs_ircmb_2024_08_003 |
| PublicationCentury | 2000 |
| PublicationDate | 2025-00-00 |
| PublicationDateYYYYMMDD | 2025-01-01 |
| PublicationDate_xml | – year: 2025 text: 2025-00-00 |
| PublicationDecade | 2020 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | International review of cell and molecular biology |
| PublicationTitleAlternate | Int Rev Cell Mol Biol |
| PublicationYear | 2025 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| References | Seyam, Esheba, Eid, Gabr (bib83) 2023; 13 Carlini, Noonan, Abdalalem, Goletti, Sansone, Calabrone (bib11) 2023; 14 Nieto, Hedjar, Locke, Caro, Saif (bib73) 2023; 4 Fernandes, Gupta, Vranic, Al Moustafa (bib21) 2020; 9 Kyle (bib52) 1975; 50 Zou, Chen (bib111) 2008; 8 Kovacs (bib48) 2010; 34 Magin, McWhir, Melton (bib61) 1992; 20 Beyar-Katz, Magidey, Reiner-Benaim, Barak, Avivi, Cohen (bib10) 2019; 17 Rios-Tamayo, Lupianez, Campa, Hielscher, Weinhold, Martinez-Lopez (bib79) 2016; 7 Chou, Yang, Chen, Yang, Yu, Hong (bib14) 2012; 89 Lin, Shen, Zhou, Liu, Xu, Huang (bib56) 2020; 20 Steinmetz, Verstappen, Suurmond, Kroese (bib92) 2023; 260 Liu, Chang, Huang (bib57) 2021; 33 Moore, de Waal Malefyt, Coffman, O’Garra (bib64) 2001; 19 Mestiri, El-Ella, Fernandes, Bedhiafi, Almoghrabi, Akbar (bib63) 2024; 171 Murray (bib67) 2017; 79 Shah, Mailankody (bib85) 2020; 370 Liu, Hamrouni, Wolowiec, Coiteux, Kuliczkowski, Hetuin (bib58) 2007; 110 Zou (bib110) 2006; 6 Riccardi, Tangredi, Dal Bo, Toffoli (bib77) 2024; 14 Sharma, Khan, Joshi, Kumar, Sharma (bib86) 2010; 51 D’Agostino, Boccadoro, Smith (bib17) 2017; 12 Kovacs-Benke (bib49) 2015; 1 Mumm, Emmerich, Zhang, Chan, Wu, Mauze (bib66) 2011; 20 Kang, Kim, Bae, Park, Lee, Chung (bib42) 2013; 6 Fernandes, Inchakalody, Bedhiafi, Mestiri, Taib, Uddin (bib22) 2024; 338 Firestone, Mailankody (bib27) 2023; 2023 Lu, Gabrilovich (bib60) 2012; 18 Mass, Nimmerjahn, Kierdorf, Schlitzer (bib62) 2023; 23 Hallett, Jing, Drobyski, Johnson (bib36) 2011; 17 Hu, Kuang, Zhou (bib39) 2023; 48 Kumari, Sharma, Advani, Khosla, Kumar, Ambasta (bib50) 2022; 29 Ahmadzadeh, Johnson, Heemskerk, Wunderlich, Dudley, White (bib3) 2009; 114 Shiri, Zhang, Bedke, Zazara, Zhao, Lucke (bib89) 2024; 80 Italiani, Boraschi (bib40) 2014; 5 Ni, Chen, Yuan, Cavezza, Wei, Li (bib70) 2019; 14 Abdullah, Abdullah, Hussen, Younis, Rasul, Taheri (bib1) 2024; 9 Alexandrakis, Goulidaki, Pappa, Boula, Psarakis, Neonakis (bib4) 2015; 21 Chen, Ning, Jiang, Peng, Zhu, Zhuang (bib13) 2019; 71 Sonneveld, Dimopoulos, Boccadoro, Quach, Ho, Beksac (bib91) 2024; 390 Xu, Xia, Zhang, Drokow, Li, Xu (bib102) 2023; 4 Fernandes, Gupta, Murshed, Abo Samra, Al-Thawadi, Vranic (bib19) 2023; 12 Fernandes, Gupta, Murshed, Samra, Al-Thawadi, Vranic (bib20) 2023; 19 Aborehab, Kandeil, Sabry, Rabie, Ibrahim (bib2) 2023; 8 Ruffell, Chang-Strachan, Chan, Rosenbusch, Ho, Pryer (bib82) 2014; 26 Yssel, De Waal Malefyt, Roncarolo, Abrams, Lahesmaa, Spits (bib103) 1992; 149 de Waal Malefyt, Haanen, Spits, Roncarolo, te Velde, Figdor (bib18) 1991; 174 Ansell, Lesokhin, Borrello, Halwani, Scott, Gutierrez (bib5) 2015; 372 Holstein (bib38) 2022; 36 Kasamatsu, Saitoh, Minato, Shimizu, Yokohama, Tsukamoto (bib44) 2016; 96 Rosenblatt, Avigan (bib80) 2017; 129 Terpos, Mikhael, Hajek, Chari, Zweegman, Lee (bib96) 2021; 11 Fernandes, Therachiyil, Khan, Bedhiafi, Korashy, Bhat (bib25) 2023; 191 Frassanito, Cusmai, Iodice, Dammacco (bib28) 2001; 97 Rapoport (bib76) 2015; 126 Liu, Xu, Liu, Zhao, Yang, Fu (bib59) 2023; 12 Muthu Raja, Kubiczkova, Rihova, Piskacek, Vsianska, Hezova (bib68) 2012; 7 Lamichhane, Karyampudi, Shreeder, Krempski, Bahr, Daum (bib54) 2017; 77 Zabransky, Jaffee, Weeraratna (bib106) 2022; 32 Wang, Wang, Chen, Wang, Chen, Geng (bib98) 2015; 6 Quigley, Pereyra, Nilsson, Porichis, Fonseca, Eichbaum (bib75) 2010; 16 Sun, Mezzadra, Schumacher (bib94) 2018; 48 Zhao, Hua, Yan, Yu, Han, Zhong (bib109) 2018; 2018 Bal, Costa (bib7) 2024; 204 Aras, Zaidi (bib6) 2017; 117 Gupta, Sharma, Sharma (bib35) 2020; 503 Jiang, Li, Zhu (bib41) 2015; 6 Sharma, Nemeth, Chen, Goodnough, Huston, Roodman (bib87) 2008; 14 Kim, Denu, Dollar, Escalante, Kuether, Callander (bib47) 2012; 158 Cowan, Green, Kwok, Lee, Coffey, Holmberg (bib16) 2022; 327 Fernandes, Sher, Prabhu, Kuttikrishnan, Merhi, Dermime (bib24) 2024; 36 Ni, Zhang, Yang, Li, Ma, Walton (bib71) 2020; 16 Kawano, Roccaro, Ghobrial, Azzi (bib45) 2017; 17 Tauriello, Palomo-Ponce, Stork, Berenguer-Llergo, Badia-Ramentol, Iglesias (bib95) 2018; 554 Yu, Liu (bib104) 2019; 12 Ouyang, O’Garra (bib74) 2019; 50 Zhang, Chen, Zhang, Dong, Yue, Wang (bib107) 2023; 124 Kyle, Rajkumar (bib53) 2004; 351 Shah, Chari, Scott, Mezzi, Usmani (bib84) 2020; 34 Finbloom, Winestock (bib26) 1995; 155 Zhang, Klein, Bataille (bib108) 1989; 74 Bebnowska, Hrynkiewicz, Grywalska, Pasiarski, Sosnowska-Pasiarska, Smarz-Widelska (bib9) 2021; 22 Fernandes, Merhi, Raza, Inchakalody, Abdelouahab, Zar Gul (bib23) 2018; 8 Keir, Butte, Freeman, Sharpe (bib46) 2008; 26 Kwasniak, Czarnik-Kwasniak, Maziarz, Aebisher, Zielinska, Karczmarek-Borowska (bib51) 2019; 44 Coussens, Werb (bib15) 2002; 420 Riley (bib78) 2009; 229 Bataille, Jourdan, Zhang, Klein (bib8) 1989; 84 Gros, Robbins, Yao, Li, Turcotte, Tran (bib33) 2014; 124 Hashem, Mohandesi Khosroshahi, Aliahmady, Ghanei, Soofi Rezaie, Alsadat Jafari (bib37) 2024; 9 Wang, Wang, Chi, Wang, Chen, Geng (bib99) 2016; 114 Shekarriz, Janbabaei, Abedian Kenari (bib88) 2018; 19 Nielsen, Rodrigo-Domingo, Steffensen, Baech, Bergkvist, Oosterhof (bib72) 2017; 58 Yue, Huang, Yang, Zhao, He, Han (bib105) 2022; 23 Sun, Fourcade, Pagliano, Chauvin, Sander, Kirkwood (bib93) 2015; 75 Garcia-Ortiz, Rodriguez-Garcia, Encinas, Maroto-Martin, Castellano, Teixido (bib30) 2021; 13 Xu, Wang, Wang, Ding, Zhou, Zhang (bib101) 2024; 9 Soekojo, Ooi, de Mel, Chng (bib90) 2020; 9 Charalampous, Kourelis (bib12) 2021; 11 Freire-de-Lima, Nardy, Ramos-Junior, Conde, Santos Lemos, da Fonseca (bib29) 2017; 4 Wynn, Chawla, Pollard (bib100) 2013; 496 Kasamatsu, Saitoh, Ino, Gotoh, Mitsui, Shimizu (bib43) 2017; 35 Mosser, Edwards (bib65) 2008; 8 Myklebust, Irish, Brody, Czerwinski, Houot, Kohrt (bib69) 2013; 121 Rossille, Gressier, Damotte, Maucort-Boulch, Pangault, Semana (bib81) 2014; 28 Goldman-Mazur, Visram, Rajkumar, Kapoor, Dispenzieri, Lacy (bib32) 2022; 12 Lewis, Pollard (bib55) 2006; 66 Gupta, Matulis, Conage-Pough, Nooka, Kaufman, Lonial (bib34) 2017; 129 Gill, Rehsia, Verma, Sareen, Dhingra (bib31) 2024; 102 Vacca, Ribatti, Presta, Minischetti, Iurlaro, Ria (bib97) 1999; 93 |
| References_xml | – volume: 370 start-page: m3176 year: 2020 ident: bib85 article-title: Emerging immunotherapies in multiple myeloma publication-title: BMJ – volume: 93 start-page: 3064 year: 1999 end-page: 3073 ident: bib97 article-title: Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma publication-title: Blood – volume: 338 year: 2024 ident: bib22 article-title: Chronic inflammation and cancer; The two sides of a coin publication-title: Life Sciences – volume: 126 start-page: 1401 year: 2015 end-page: 1403 ident: bib76 article-title: Myeloma escape from immunity: An “inside” job publication-title: Blood – volume: 8 start-page: 467 year: 2008 end-page: 477 ident: bib111 article-title: Inhibitory B7-family molecules in the tumour microenvironment publication-title: Nature Reviews Immunology – volume: 77 start-page: 6667 year: 2017 end-page: 6678 ident: bib54 article-title: IL10 release upon PD-1 blockade sustains immunosuppression in ovarian cancer publication-title: Cancer Research – volume: 13 start-page: 34 year: 2023 end-page: 39 ident: bib83 article-title: Red cell distribution width, neutrophil lymphocyte ratio and interleukin 10 are good prognostic markers in multiple myeloma publication-title: Biomedicine (Taipei) – volume: 35 start-page: 711 year: 2017 end-page: 718 ident: bib43 article-title: Polymorphism of IL-10 receptor beta affects the prognosis of multiple myeloma patients treated with thalidomide and/or bortezomib publication-title: Hematol. Oncol – volume: 19 start-page: 2220626 year: 2023 ident: bib20 article-title: Incidence and association of high-risk HPVs and EBV in patients with advanced stages of colorectal cancer from Qatar publication-title: Human Vaccines & Immunotherapeutics – volume: 9 year: 2020 ident: bib21 article-title: Human papillomaviruses and epstein-barr virus interactions in colorectal cancer: A brief review publication-title: Pathogens – volume: 96 start-page: 245 year: 2016 end-page: 251 ident: bib44 article-title: Polymorphisms of IL-10 affect the severity and prognosis of myelodysplastic syndrome publication-title: European Journal of Haematology – volume: 155 start-page: 1079 year: 1995 end-page: 1090 ident: bib26 article-title: IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes publication-title: Journal of Immunology – volume: 129 start-page: 275 year: 2017 end-page: 279 ident: bib80 article-title: Targeting the PD-1/PD-L1 axis in multiple myeloma: A dream or a reality? publication-title: Blood – volume: 124 year: 2023 ident: bib107 article-title: Interleukin-10 increases macrophage-mediated chemotherapy resistance via FABP5 signaling in multiple myeloma publication-title: International Immunopharmacology – volume: 36 start-page: 1 year: 2024 end-page: 15 ident: bib24 article-title: Beyond viral infections: The multifaceted roles of human papillomavirus and Epstein-Barr virus in shaping the tumor microenvironment publication-title: Discovery Medicine – volume: 33 start-page: 257 year: 2021 end-page: 262 ident: bib57 article-title: The perspectives of interleukin-10 in the pathogenesis and therapeutics of multiple myeloma publication-title: Tzu Chi Medical Journal – volume: 14 start-page: 3262 year: 2008 end-page: 3267 ident: bib87 article-title: Involvement of hepcidin in the anemia of multiple myeloma publication-title: Clinical Cancer Research – volume: 16 start-page: 2328 year: 2020 end-page: 2332 ident: bib71 article-title: Targeting interleukin-10 signalling for cancer immunotherapy, a promising and complicated task publication-title: Human Vaccines & Immunotherapeutics – volume: 12 start-page: 344 year: 2017 end-page: 357 ident: bib17 article-title: Novel immunotherapies for multiple myeloma publication-title: Curr. Hematol. Malig. Rep. – volume: 48 start-page: 1403 year: 2023 end-page: 1410 ident: bib39 article-title: Advances in the pathogenesis of multiple myeloma bone disease publication-title: Zhong Nan Da Xue Xue Bao Yi Xue Ban – volume: 26 start-page: 623 year: 2014 end-page: 637 ident: bib82 article-title: Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells publication-title: Cancer Cell – volume: 372 start-page: 311 year: 2015 end-page: 319 ident: bib5 article-title: PD-1 blockade with nivolumab in relapsed or refractory Hodgkin’s lymphoma publication-title: New England Journal of Medicine – volume: 51 start-page: 920 year: 2010 end-page: 927 ident: bib86 article-title: Dysregulation in T helper 1/T helper 2 cytokine ratios in patients with multiple myeloma publication-title: Leukemia & Lymphoma – volume: 114 start-page: 463 year: 2016 end-page: 468 ident: bib99 article-title: High level of interleukin-10 in serum predicts poor prognosis in multiple myeloma publication-title: British Journal of Cancer – volume: 97 start-page: 483 year: 2001 end-page: 489 ident: bib28 article-title: Autocrine interleukin-6 production and highly malignant multiple myeloma: Relation with resistance to drug-induced apoptosis publication-title: Blood – volume: 2018 start-page: 7569809 year: 2018 ident: bib109 article-title: The genetic polymorphisms of NLRP3 inflammasome associated with T helper cells in patients with multiple myeloma publication-title: Journal of Immunology Research – volume: 4 year: 2023 ident: bib102 article-title: Macrophages facilitate tumor cell PD-L1 expression via an IL-1beta-centered loop to attenuate immune checkpoint blockade publication-title: MedComm (2020) – volume: 6 start-page: 282 year: 2013 end-page: 289 ident: bib42 article-title: Tumor-infiltrating PD1-positive lymphocytes and FoxP3-positive regulatory T cells predict distant metastatic relapse and survival of clear cell renal cell carcinoma publication-title: Translational Oncology – volume: 4 start-page: 35 year: 2023 end-page: 42 ident: bib73 article-title: Analysis of updates in multiple myeloma treatment and management publication-title: Journal of Clinical Haematology – volume: 34 start-page: 912 year: 2010 end-page: 916 ident: bib48 article-title: Interleukin-6 leads to interleukin-10 production in several human multiple myeloma cell lines. Does interleukin-10 enhance the proliferation of these cells? publication-title: Leukemia Research – volume: 1 start-page: 47 year: 2015 end-page: 78 ident: bib49 article-title: Additive/synergistic effects of interleukin-6 and interleukin-10 on the proliferation of human myeloma cells publication-title: International Journal of Hematology Research – volume: 21 start-page: 929 year: 2015 end-page: 934 ident: bib4 article-title: Interleukin-10 induces both plasma cell proliferation and angiogenesis in multiple myeloma publication-title: Pathol. Oncol. Res. – volume: 14 year: 2019 ident: bib70 article-title: Comparative proteomic study reveals the enhanced immune response with the blockade of interleukin 10 with anti-IL-10 and anti-IL-10 receptor antibodies in human U937 cells publication-title: PLoS One – volume: 11 year: 2021 ident: bib12 article-title: Minimal residual disease assessment in multiple myeloma patients: Minimal disease with maximal implications publication-title: Frontiers in Oncology – volume: 8 start-page: 257 year: 2018 ident: bib23 article-title: Role of Epstein-Barr virus in the pathogenesis of head and neck cancers and its potential as an immunotherapeutic target publication-title: Frontiers in Oncology – volume: 114 start-page: 1537 year: 2009 end-page: 1544 ident: bib3 article-title: Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired publication-title: Blood – volume: 124 start-page: 2246 year: 2014 end-page: 2259 ident: bib33 article-title: PD-1 identifies the patient-specific CD8(+) tumor-reactive repertoire infiltrating human tumors publication-title: Journal of Clinical Investigation – volume: 204 start-page: 449 year: 2024 end-page: 454 ident: bib7 article-title: Bridging treatment prior to chimeric antigen receptor T-cell therapy in multiple myeloma publication-title: British Journal of Haematology – volume: 351 start-page: 1860 year: 2004 end-page: 1873 ident: bib53 article-title: Multiple myeloma publication-title: New England Journal of Medicine – volume: 5 start-page: 514 year: 2014 ident: bib40 article-title: From monocytes to M1/M2 macrophages: Phenotypical vs. functional differentiation publication-title: Frontiers in Immunology – volume: 48 start-page: 434 year: 2018 end-page: 452 ident: bib94 article-title: Regulation and function of the PD-L1 checkpoint publication-title: Immunity – volume: 12 start-page: 99 year: 2023 ident: bib59 article-title: Immune checkpoint inhibitors for multiple myeloma immunotherapy publication-title: Experimental Hematology & Oncology – volume: 80 start-page: 634 year: 2024 end-page: 644 ident: bib89 article-title: IL-10 dampens antitumor immunity and promotes liver metastasis via PD-L1 induction publication-title: Journal of Hepatology – volume: 84 start-page: 2008 year: 1989 end-page: 2011 ident: bib8 article-title: Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias publication-title: Journal of Clinical Investigation – volume: 9 start-page: 560 year: 2024 end-page: 582 ident: bib37 article-title: Non-coding RNA transcripts, incredible modulators of cisplatin chemo-resistance in bladder cancer through operating a broad spectrum of cellular processes and signaling mechanism publication-title: Non-coding RNA Research – volume: 121 start-page: 1367 year: 2013 end-page: 1376 ident: bib69 article-title: High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells publication-title: Blood – volume: 19 start-page: 683 year: 2001 end-page: 765 ident: bib64 article-title: Interleukin-10 and the interleukin-10 receptor publication-title: Annual Review of Immunology – volume: 2023 start-page: 340 year: 2023 end-page: 347 ident: bib27 article-title: Current use of CAR T cells to treat multiple myeloma publication-title: Hematology: The American Society of Hematology Education Program – volume: 17 start-page: 806 year: 2017 end-page: 818 ident: bib45 article-title: Multiple myeloma and the immune microenvironment publication-title: Current Cancer Drug Targets – volume: 6 year: 2015 ident: bib41 article-title: T-cell exhaustion in the tumor microenvironment publication-title: Cell Death and Disease – volume: 390 start-page: 301 year: 2024 end-page: 313 ident: bib91 article-title: Daratumumab, bortezomib, lenalidomide, and dexamethasone for multiple myeloma publication-title: New England Journal of Medicine – volume: 22 year: 2021 ident: bib9 article-title: Immunological prognostic factors in multiple myeloma publication-title: International Journal of Molecular Sciences – volume: 75 start-page: 1635 year: 2015 end-page: 1644 ident: bib93 article-title: IL10 and PD-1 cooperate to limit the activity of tumor-specific CD8+ T cells publication-title: Cancer Research – volume: 420 start-page: 860 year: 2002 end-page: 867 ident: bib15 article-title: Inflammation and cancer publication-title: Nature – volume: 129 start-page: 1969 year: 2017 end-page: 1979 ident: bib34 article-title: Bone marrow microenvironment-derived signals induce Mcl-1 dependence in multiple myeloma publication-title: Blood – volume: 8 start-page: 401 year: 2023 end-page: 412 ident: bib2 article-title: Circular SERPINA3 and its target microRNA-944 as potential biomarkers in hepatitis C virus-induced hepatocellular carcinoma in Egyptian population publication-title: Noncoding RNA Research – volume: 71 start-page: 333 year: 2019 end-page: 343 ident: bib13 article-title: Glycolytic activation of peritumoral monocytes fosters immune privilege via the PFKFB3-PD-L1 axis in human hepatocellular carcinoma publication-title: Journal of Hepatology – volume: 44 start-page: 190 year: 2019 end-page: 200 ident: bib51 article-title: Scientific reports concerning the impact of interleukin 4, interleukin 10 and transforming growth factor beta on cancer cells publication-title: Central European Journal of Immunology – volume: 8 start-page: 958 year: 2008 end-page: 969 ident: bib65 article-title: Exploring the full spectrum of macrophage activation publication-title: Nature Reviews Immunology – volume: 12 start-page: 164 year: 2022 ident: bib32 article-title: Second- and third-line treatment strategies in multiple myeloma: A referral-center experience publication-title: Blood Cancer Journal – volume: 23 start-page: 563 year: 2023 end-page: 579 ident: bib62 article-title: Tissue-specific macrophages: How they develop and choreograph tissue biology publication-title: Nature Reviews Immunology – volume: 503 start-page: 45 year: 2020 end-page: 53 ident: bib35 article-title: Emerging biomarkers in multiple myeloma: A review publication-title: Clinica Chimica Acta – volume: 50 start-page: 871 year: 2019 end-page: 891 ident: bib74 article-title: IL-10 family cytokines IL-10 and IL-22: From basic science to clinical translation publication-title: Immunity – volume: 50 start-page: 29 year: 1975 end-page: 40 ident: bib52 article-title: Multiple myeloma: Review of 869 cases publication-title: Mayo Clinic Proceedings – volume: 496 start-page: 445 year: 2013 end-page: 455 ident: bib100 article-title: Macrophage biology in development, homeostasis and disease publication-title: Nature – volume: 13 year: 2021 ident: bib30 article-title: The role of tumor microenvironment in multiple myeloma development and progression publication-title: Cancers (Basel) – volume: 158 start-page: 336 year: 2012 end-page: 346 ident: bib47 article-title: Macrophages and mesenchymal stromal cells support survival and proliferation of multiple myeloma cells publication-title: British Journal of Haematology – volume: 11 start-page: 40 year: 2021 ident: bib96 article-title: Management of patients with multiple myeloma beyond the clinical-trial setting: Understanding the balance between efficacy, safety and tolerability, and quality of life publication-title: Blood Cancer Journal – volume: 7 start-page: 59029 year: 2016 end-page: 59048 ident: bib79 article-title: A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: Results from the IMMEnSE consortium and meta-analysis publication-title: Oncotarget – volume: 20 start-page: 781 year: 2011 end-page: 796 ident: bib66 article-title: IL-10 elicits IFNgamma-dependent tumor immune surveillance publication-title: Cancer Cell – volume: 89 start-page: 320 year: 2012 end-page: 327 ident: bib14 article-title: Pre-existing diabetes mellitus in patients with multiple myeloma publication-title: European Journal of Haematology – volume: 110 start-page: 296 year: 2007 end-page: 304 ident: bib58 article-title: Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-gamma and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway publication-title: Blood – volume: 229 start-page: 114 year: 2009 end-page: 125 ident: bib78 article-title: PD-1 signaling in primary T cells publication-title: Immunological Reviews – volume: 28 start-page: 2367 year: 2014 end-page: 2375 ident: bib81 article-title: High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: Results from a French multicenter clinical trial publication-title: Leukemia – volume: 20 start-page: 699 year: 2020 ident: bib56 article-title: Assessment of infection in newly diagnosed multiple myeloma patients: Risk factors and main characteristics publication-title: BMC Infectious Diseases – volume: 19 start-page: 27 year: 2018 end-page: 32 ident: bib88 article-title: Prognostic value of IL-10 and its relationship with disease stage in Iranian patients with multiple myeloma publication-title: Asian Pacific Journal of Cancer Prevention – volume: 12 year: 2023 ident: bib19 article-title: Coinfection of HPVs is associated with advanced stage in colorectal cancer patients from Qatar publication-title: Pathogens – volume: 74 start-page: 11 year: 1989 end-page: 13 ident: bib108 article-title: Interleukin-6 is a potent myeloma-cell growth factor in patients with aggressive multiple myeloma publication-title: Blood – volume: 58 start-page: 2695 year: 2017 end-page: 2704 ident: bib72 article-title: Interactions between SNPs affecting inflammatory response genes are associated with multiple myeloma disease risk and survival publication-title: Leukemia & Lymphoma – volume: 34 start-page: 985 year: 2020 end-page: 1005 ident: bib84 article-title: B-cell maturation antigen (BCMA) in multiple myeloma: Rationale for targeting and current therapeutic approaches publication-title: Leukemia – volume: 260 start-page: 44 year: 2023 end-page: 57 ident: bib92 article-title: Targeting plasma cells in systemic autoimmune rheumatic diseases—Promises and pitfalls publication-title: Immunol. Lett. – volume: 17 start-page: 1133 year: 2011 end-page: 1145 ident: bib36 article-title: Immunosuppressive effects of multiple myeloma are overcome by PD-L1 blockade publication-title: Biology of Blood and Marrow Transplantation – volume: 36 start-page: 430 year: 2022 end-page: 441 ident: bib38 article-title: Current frontline treatment of multiple myeloma publication-title: Oncology (Williston Park) – volume: 29 start-page: 62111 year: 2022 end-page: 62159 ident: bib50 article-title: Unboxing the molecular modalities of mutagens in cancer publication-title: Environmental Science and Pollution Research International – volume: 554 start-page: 538 year: 2018 end-page: 543 ident: bib95 article-title: TGFbeta drives immune evasion in genetically reconstituted colon cancer metastasis publication-title: Nature – volume: 66 start-page: 605 year: 2006 end-page: 612 ident: bib55 article-title: Distinct role of macrophages in different tumor microenvironments publication-title: Cancer Research – volume: 16 start-page: 1147 year: 2010 end-page: 1151 ident: bib75 article-title: Transcriptional analysis of HIV-specific CD8+ T cells shows that PD-1 inhibits T cell function by upregulating BATF publication-title: Nature Medicine – volume: 102 start-page: 161 year: 2024 end-page: 179 ident: bib31 article-title: Stem cell therapy for cardiac regeneration: Past, present, and future publication-title: Canadian Journal of Physiology and Pharmacology – volume: 18 start-page: 4877 year: 2012 end-page: 4882 ident: bib60 article-title: Molecular pathways: Tumor-infiltrating myeloid cells and reactive oxygen species in regulation of tumor microenvironment publication-title: Clinical Cancer Research – volume: 7 year: 2012 ident: bib68 article-title: Functionally suppressive CD8 T regulatory cells are increased in patients with multiple myeloma: A cause for immune impairment publication-title: PLoS One – volume: 9 year: 2020 ident: bib90 article-title: Immunotherapy in multiple myeloma publication-title: Cells – volume: 191 year: 2023 ident: bib25 article-title: Shrinking the battlefield in cancer therapy: Nanotechnology against cancer stem cells publication-title: European Journal of Pharmaceutical Sciences – volume: 17 start-page: 2331 year: 2019 end-page: 2340 ident: bib10 article-title: Proinflammatory macrophages promote multiple myeloma resistance to bortezomib therapy publication-title: Molecular Cancer Research – volume: 12 start-page: 94 year: 2019 ident: bib104 article-title: Antibody-drug conjugates in clinical trials for lymphoid malignancies and multiple myeloma publication-title: Journal of Hematology & Oncology – volume: 4 start-page: 92 year: 2017 ident: bib29 article-title: Multiple myeloma cells express key immunoregulatory cytokines and modulate the monocyte migratory response publication-title: Frontiers in Medicine (Lausanne) – volume: 149 start-page: 2378 year: 1992 end-page: 2384 ident: bib103 article-title: IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells publication-title: Journal of Immunology – volume: 32 start-page: 338 year: 2022 end-page: 350 ident: bib106 article-title: Shared genetic and epigenetic changes link aging and cancer publication-title: Trends in Cell Biology – volume: 6 start-page: 41228 year: 2015 end-page: 41236 ident: bib98 article-title: Serum levels of soluble programmed death ligand 1 predict treatment response and progression free survival in multiple myeloma publication-title: Oncotarget – volume: 23 start-page: 968 year: 2022 end-page: 974 ident: bib105 article-title: High levels of serum IL-10 indicate disease progression, extramedullary involvement, and poor prognosis in multiple myeloma publication-title: Journal of Zhejiang University Science B – volume: 327 start-page: 464 year: 2022 end-page: 477 ident: bib16 article-title: Diagnosis and management of multiple myeloma: A review publication-title: JAMA – volume: 117 start-page: 1583 year: 2017 end-page: 1591 ident: bib6 article-title: TAMeless traitors: Macrophages in cancer progression and metastasis publication-title: British Journal of Cancer – volume: 174 start-page: 915 year: 1991 end-page: 924 ident: bib18 article-title: Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression publication-title: Journal of Experimental Medicine – volume: 79 start-page: 541 year: 2017 end-page: 566 ident: bib67 article-title: Macrophage polarization publication-title: Annual Review of Physiology – volume: 14 start-page: 1370854 year: 2024 ident: bib77 article-title: Targeted therapy for multiple myeloma: An overview on CD138-based strategies publication-title: Front. Oncol. – volume: 6 start-page: 295 year: 2006 end-page: 307 ident: bib110 article-title: Regulatory T cells, tumour immunity and immunotherapy publication-title: Nature Reviews Immunology – volume: 14 start-page: 1161067 year: 2023 ident: bib11 article-title: The multifaceted nature of IL-10: Regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions publication-title: Front. Immunol. – volume: 9 start-page: 388 year: 2024 end-page: 406 ident: bib101 article-title: Long noncoding RNA MALAT-1: A versatile regulator in cancer progression, metastasis, immunity, and therapeutic resistance publication-title: Non-coding RNA Research – volume: 9 start-page: 236 year: 2024 end-page: 252 ident: bib1 article-title: Role of circular RNAs and gut microbiome in gastrointestinal cancers and therapeutic targets publication-title: Noncoding RNA Research – volume: 26 start-page: 677 year: 2008 end-page: 704 ident: bib46 article-title: PD-1 and its ligands in tolerance and immunity publication-title: Annual Review of Immunology – volume: 171 year: 2024 ident: bib63 article-title: The dynamic role of immune checkpoint molecules in diagnosis, prognosis, and treatment of head and neck cancers publication-title: Biomedicine & Pharmacotherapy – volume: 20 start-page: 3795 year: 1992 end-page: 3796 ident: bib61 article-title: A new mouse embryonic stem cell line with good germ line contribution and gene targeting frequency publication-title: Nucleic Acids Research |
| SSID | ssj0063035 |
| Score | 2.4349546 |
| SecondaryResourceType | review_article |
| Snippet | [Display omitted]
Multiple myeloma (MM) is a complex hematologic malignancy characterized by the abnormal proliferation of plasma cells in the bone marrow,... Multiple myeloma (MM) is a complex hematologic malignancy characterized by the abnormal proliferation of plasma cells in the bone marrow, leading to... |
| SourceID | proquest pubmed elsevier |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 199 |
| SubjectTerms | Animals Humans Il-10, Circulatory biomarkers Immunotherapy Interleukin-10 - immunology Interleukin-10 - metabolism Multiple myeloma Multiple Myeloma - immunology Multiple Myeloma - pathology Tumor Microenvironment - immunology |
| Title | Interleukin 10: Bridging the chasms in the immune landscape of multiple myeloma |
| URI | https://dx.doi.org/10.1016/bs.ircmb.2024.08.003 https://www.ncbi.nlm.nih.gov/pubmed/39939076 https://www.proquest.com/docview/3166263412 |
| Volume | 391 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELegE2gviG_Kl4zEW5QRJ6mT8FYQaGIqCLSJvVm2Y4tsTTo16UP56zl_tWVsEvCSNLFkWb5fz3eX-90h9FoXWck1r2NS1zLOqaxiURIdC6LShFYTwwU12Raf6eFJ_ul0croN5lh2ySAO5M8reSX_I1V4B3I1LNl_kOxmUngBv0G-cAUJw_WvZGzDeXO1Om-6iCTGuX9n-FeBASV_8L7tQyZjY5ggKrLcXpP1ZL-sh3TCdq3mC6-iz3Ym38QKtxQXE-q3nxza0Fk38pWcLsemLUS-Gk-52QKr67kjt09FvZpHmxDPjJ93TTzjcGCdeZYa354ZM7W03YejGV_3fA4qajdc4UjNXrdWhpGYu8KaQflmrleXV5_ENUv6Q627CIPoD5qlbAV49WluC6_a8gjDjqQvWitqY3WB13-pxrY7tf3QTbSXgmeRjtDe9Ojb96NwfFM40ycuFcGtNvAtCX1z1QL20e0w5W_2zHX-irVbju-iO97hwFOHnnvohuruo1uuBen6AfqygyFMkrc4IAgDZrBDEIYh8-QQhDcIwguNA4KwR9BDdPLxw_H7w9g32YgVGHdDzBNRVAkVdS40GCuUl6LUUhBKk5qWfFLDI_zPDSW7rHUldJoLMLFlJdIiIbXIHqFRt-jUE4SrsqI80QXXmuYyJ5yISpRCSqrgVvMxKsL-MG_fObuNgZxZSDcUPbObzMwmM9MjNcnG6FXYTgbqzwCdd2qx6lkGC00pmGLpGD12-8wuXJ0WFuTy9NqRZ2jfYNSF1J6j0bBcqRdgZA7ipYfFL5Yzfwg |
| linkProvider | Library Specific Holdings |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Interleukin+10%3A+Bridging+the+chasms+in+the+immune+landscape+of+multiple+myeloma&rft.jtitle=International+review+of+cell+and+molecular+biology&rft.au=Fernandes%2C+Queenie&rft.au=Ansari%2C+Abdul+W&rft.au=Makni-Maalej%2C+Karama&rft.au=Merhi%2C+Maysaloun&rft.date=2025&rft.issn=1937-6448&rft.volume=391&rft.spage=199&rft_id=info:doi/10.1016%2Fbs.ircmb.2024.08.003&rft_id=info%3Apmid%2F39939076&rft.externalDocID=39939076 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1937-6448&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1937-6448&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1937-6448&client=summon |